KS
Kedarmal Shankarlal Bankda
About Kedarmal Shankarlal Bankda
Data last updated:
Kedarmal Shankarlal Bankda is a Director at Vincit Biotech International Private Limited (since 2022), Director at Synmex Pharma Private Limited (since 2022) and Whole-Time Director at Syncom Formulations (India) Limited (since 1992), and holds 1 more current directorship. The companies operate in Pharma and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹26.12 Cr; the largest is Vincit Biotech International Private Limited at ₹13.14 Cr (FY 2025). Earlier, Kedarmal Shankarlal Bankda was a Director at Arp Pharma Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2022 | 2022 | ₹13.14 Cr (FY 2025) | Active | |
| Director | 21 Jul 2022 | 2022 | ₹7.09 Cr (FY 2025) | Active | |
| Whole-Time Director | 13 Apr 1992 | 1988 | ₹5.88 Cr (FY 2025) | Active | |
| Director | 21 Jul 2022 | 2022 | ₹1.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Aug 2008 | 1996 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kedarmal Shankarlal Bankda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Shankarlal Bankda | 00023027 | Vincit Biotech International Private Limited , Synmex Pharma Private Limited and 2 more | Director |
| Ankit Jain | 05341403 | Syncom Formulations (India) Limited | Director |
| Ankit Kedarmal Bankda | 02359461 | Syncom Formulations (India) Limited | Whole-Time Director |
| Rahul Vijay Bankda | Syncom Formulations (India) Limited | Cfo | |
| Ritesh Kumar Lunkad | 10275445 | Syncom Formulations (India) Limited | Director |
| Ruchi Jindal | 09633465 | Syncom Formulations (India) Limited | Director |
| Vaishali Agrawal | Syncom Formulations (India) Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kedarmal Shankarlal Bankda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kedarmal Shankarlal Bankda
Kedarmal Shankarlal Bankda currently holds 4 directorships: Vincit Biotech International Private Limited (Director, since 25 Jul 2022, revenue ₹13.14 Cr (FY 2025)); Synmex Pharma Private Limited (Director, since 21 Jul 2022, revenue ₹7.09 Cr (FY 2025)); Syncom Formulations (India) Limited (Whole-Time Director, since 13 Apr 1992, revenue ₹5.88 Cr (FY 2025)); Sante Biotech Private Limited (Director, since 21 Jul 2022, revenue ₹1.5 Lakh (FY 2025)).
Kedarmal Shankarlal Bankda was first appointed on 13 Apr 1992 as Whole-Time Director at Syncom Formulations (India) Limited. The most recent appointment on record is 25 Jul 2022 at Vincit Biotech International Private Limited.
The 4 current companies of Kedarmal Shankarlal Bankda that report revenue have a combined latest revenue of ₹26.12 Cr: Vincit Biotech International Private Limited ₹13.14 Cr (FY 2025); Synmex Pharma Private Limited ₹7.09 Cr (FY 2025); Syncom Formulations (India) Limited ₹5.88 Cr (FY 2025); Sante Biotech Private Limited ₹1.5 Lakh (FY 2025).
Kedarmal Shankarlal Bankda held 1 earlier board appointment: Arp Pharma Private Limited (Director, from 30 Aug 2008).
The current boards of Kedarmal Shankarlal Bankda's companies include Vijay Shankarlal Bankda (Vincit Biotech International Private Limited), Ankit Jain (Syncom Formulations (India) Limited), Ankit Kedarmal Bankda (Syncom Formulations (India) Limited), Rahul Vijay Bankda (Syncom Formulations (India) Limited), Ritesh Kumar Lunkad (Syncom Formulations (India) Limited), Ruchi Jindal (Syncom Formulations (India) Limited), among others.